PROCEPT BioRobotics (PRCT) Free Cash Flow (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Free Cash Flow data on file, last reported at -$41.0 million in Q1 2026.

• On a quarterly basis, Free Cash Flow fell 123.44% year-over-year to -$41.0 million in Q1 2026; TTM through Mar 2026 was -$81.0 million, a 4.78% increase from a year earlier, with the FY2025 full-year figure at -$58.3 million, up 41.4% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$41.0 million, down from -$12.2 million in the prior quarter.
• Over the last five years, Free Cash Flow for PRCT reached as high as -$9.5 million in Q3 2025 and fell as low as -$41.3 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$23.1 million across 5 years, with a median of -$18.6 million in 2022.
• Across the five-year window, Free Cash Flow plunged 221.83% in 2024 and soared 62.78% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$26.9 million in 2022, then jumped by 62.26% to -$10.2 million in 2023, then plunged by 221.83% to -$32.7 million in 2024, then surged by 62.78% to -$12.2 million in 2025, then slumped by 237.04% to -$41.0 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$41.0 million in Q1 2026, -$12.2 million in Q4 2025, and -$9.5 million in Q3 2025.